LISDEXAMFETAMINE DIMESYLATE
NDC 31722-350, Lisdexamfetamine dimesylate, capsule, from Camber Pharmaceuticals, Inc..
- Product NDC
- 31722-350
- Status
- Listed
- Labeler
- Camber Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217442
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/31722-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE10 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 31722-350-01 | 31722035001 | 100 CAPSULE in 1 BOTTLE (31722-350-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/20baa61e-be0b-41a3-a896-29e8ce8c4799NADAC price for package 31722035001
GET /v1/drugs/nadac/31722035001
Use it
Look up 31722-350 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/31722-350 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 31722-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.